Koers Invictus MD Strategies Corp Toronto S.E.
Aandelen
GENE
CA46183X2086
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- CAD | - |
|
Omzet 2018 | 2,36 3,22 2,19 | Omzet 2019 | 4,69 6,4 4,35 | Marktkapitalisatie | 104 mln. 141 mln. 95,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -19 mln. -25,91 mln. -17,61 mln. | Nettowinst (verlies) 2019 | -35 mln. -47,73 mln. -32,44 mln. | EV/omzet 2018 | 45.833.024 x |
Nettoliquiditeiten 2018 | 37,59 mln. 51,26 mln. 34,84 mln. | Nettoschuld 2019 | 3,85 mln. 5,24 mln. 3,56 mln. | EV/omzet 2019 | 22.877.117 x |
K/w-verhouding 2018 |
-5,87
x | K/w-verhouding 2019 |
-2,45
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 6,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Imran Haider
CEO | Chief Executive Officer | - | - |
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Larry Heinzlmeir
IRO | Public Communications Contact | - | 24-01-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Trevor Dixon
BRD | Director/Board Member | - | 09-05-19 |
Jagdeep Gupta
BRD | Director/Board Member | - | 22-02-22 |
Greg Macdonald
BRD | Director/Board Member | - | 26-01-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+23,84% | 5,56 mld. | |
-33,64% | 3,55 mld. | |
-5,20% | 3,01 mld. | |
-25,56% | 2,64 mld. | |
-10,76% | 2,3 mld. | |
+42,02% | 1,95 mld. | |
+43,15% | 1,52 mld. | |
-12,72% | 1,45 mld. | |
+41,90% | 1,38 mld. |
- Beurs
- Aandelen
- Koers IVITF
- Koers GENE